Myriad Genetics | MYGN - Des Atouts

Prix De L'Action
4.78
Variation Quotidienne
-0.01 -0.21%
Mensuellement
2.14%
Annuel
-35.58%
Q2 Prévisions
4.68




Des Atouts Changement Date
Agilent USD 12.81B 86M 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Danaher USD 83.54B 80M 2026-03
Illumina USD 6.64B 467M 2025-12
J&J USD 200.89B 1.68B 2026-03
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Quidel USD 5.77B 94.2M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Standard Biotools USD 567.75M 28.12M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Veracyte USD 1.41B 38.23M 2025-12
Waters USD 5.08B 221.41M 2025-12